Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Renal Cell

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Completed

Caphosol in Oral Mucositis Due to Targeted Therapy

NCT01265810

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +29 more
Locations: The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands

Leiden University Medical Centre (LUMC) Leiden, Netherlands

View Trial Details

Completed

An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

NCT00992121

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom

View Trial Details

Completed

Sorafenib in Elderly mRCC

NCT01728948

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Many Locations, China

View Trial Details

Completed

Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

NCT00331409

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)

NCT02809404

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +19 more
Locations: Radboud university medical center Nijmegen, Netherlands

View Trial Details

Completed

Fluorescence Imaging in Finding Tumors in Patients With Kidney Tumors

NCT01281488

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

NCT01265901

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Cedars-Siani Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States

Kaiser Permanente Oncology Hematology Clinic Denver, Colorado, United States

Georgetown University Medical Center, Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States

View all 105 locations

View Trial Details

Completed

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

NCT00499135

Conditions: Adenocarcinoma, Adult Solid Neoplasm, Carcinoma, +18 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell Carcinoma

NCT01351571

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Aurangabad, India

Delhi, India

View Trial Details

Completed

A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread

NCT03161145

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Local Institution Tokyo, Japan

View Trial Details